Cue Biopharma, Inc. (CUE)
23.18
-0.80
(-3.34%)
USD |
NASDAQ |
Aug 24, 16:00
23.16
-0.02
(-0.09%)
Pre-Market: 20:00
Cue Biopharma 1 Year Total Returns (Daily) : -6.46% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -6.46% |
| August 21, 2026 | -1.49% |
| August 20, 2026 | 1.48% |
| August 19, 2026 | 7.35% |
| August 18, 2026 | 4.62% |
| August 17, 2026 | 11.54% |
| August 14, 2026 | 44.30% |
| August 13, 2026 | 27.85% |
| August 12, 2026 | 28.35% |
| August 11, 2026 | 13.22% |
| August 10, 2026 | 4.69% |
| August 07, 2026 | 11.60% |
| August 06, 2026 | 14.98% |
| August 05, 2026 | 5.99% |
| August 04, 2026 | 16.36% |
| August 03, 2026 | 21.49% |
| July 31, 2026 | 19.19% |
| July 30, 2026 | 24.41% |
| July 29, 2026 | 13.82% |
| July 28, 2026 | 22.92% |
| July 27, 2026 | 22.96% |
| July 24, 2026 | 18.30% |
| July 23, 2026 | 23.93% |
| July 22, 2026 | 26.81% |
| July 21, 2026 | 26.31% |
| Date | Value |
|---|---|
| July 20, 2026 | 14.63% |
| July 17, 2026 | 23.65% |
| July 16, 2026 | 8.22% |
| July 15, 2026 | 35.67% |
| July 14, 2026 | 34.19% |
| July 13, 2026 | 34.55% |
| July 10, 2026 | 54.02% |
| July 09, 2026 | 55.37% |
| July 08, 2026 | 60.75% |
| July 07, 2026 | 58.95% |
| July 06, 2026 | 55.80% |
| July 02, 2026 | 36.13% |
| July 01, 2026 | 40.49% |
| June 30, 2026 | 54.18% |
| June 29, 2026 | 36.89% |
| June 26, 2026 | 7.21% |
| June 25, 2026 | 8.31% |
| June 24, 2026 | 19.87% |
| June 23, 2026 | 36.89% |
| June 22, 2026 | 46.19% |
| June 18, 2026 | 44.72% |
| June 17, 2026 | 53.59% |
| June 16, 2026 | 34.97% |
| June 15, 2026 | 42.86% |
| June 12, 2026 | 28.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 225.2% |
| Fortress Biotech, Inc. | 29.07% |
| Equillium, Inc. | 15.79% |
| Legend Biotech Corp. | -41.11% |
| Nurix Therapeutics, Inc. | 159.1% |